| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
3 companies
Lieber Jonathan I is a Chief Financial Officer at OCGN, with reported holdings spanning 3 companies. Recent filings cover 3 purchases and 1 sale. Those positions are worth an estimated $84K at current prices.
Our model assigns Lieber Jonathan I a below-average insider score of 26/100, based on 3 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -64.6%.
Lieber Jonathan I's largest disclosed position is in RLYB as Chief Financial Officer, worth about $66K. Net of sales, the recent Form 4 record there shows accumulation of 4,211 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | RLYB Rallybio Corporation | Chief Financial Officer | Sell | 789 | $5.06 | $3,992.34 | -16.1% | +188.7% | - | |
| Mar 14, 2023 | RLYB Rallybio Corp | See Remarks | Buy | 5,000 | $5.21 | $26,050.00 | New | +51.0% | -66.6% | |
| Jun 7, 2022 | DCOY Salarius Pharmaceuticals, Inc. | - | Buy | 37,500 | $0.19 | $7,016.25 | New | +7.0% | -62.5% | |
| Dec 2, 2016 | OCGN Ocugen, Inc. | Chief Financial Officer | Buy | 5,000 | $1.95 | $9,730.50 | New | - | - |